APR 20, 2021 7:30 AM PDT

Scientists Map the Genetic Landscape of COVID Infections

WRITTEN BY: Tara Fernandez

Scientists have identified 65 human immune genes activated during SARS-CoV-2 infection. This finding provides valuable insights into why some individuals experience more severe COVID symptoms than others and paves the way for novel therapeutic interventions.

The study, published in Molecular Cell, was led by Sumit K. Chanda and colleagues from Sanford Burnham Prebys. They found that interferon-stimulated genes, or ISGs, play a key role in determining COVID severity. Interferons are signaling proteins that are central to the body’s ability to protect itself from viral attacks.

"We wanted to gain a better understanding of the cellular response to SARS-CoV-2, including what drives a strong or weak response to infection," said Chanda.

"We've gained new insights into how the virus exploits the human cells it invades, but we are still searching for its Achilles heel so that we can develop optimal antivirals."

The researchers found that a panel of 65 ISGs controlled the dynamics of SARS-CoV-2 infection in a multifaceted way, inhibiting the coronavirus’ ability to invade cells and stopping the virus from replicating in human cells.

"We identified eight ISGs that inhibited both SARS-CoV-1 and CoV-2 replication in the subcellular compartment responsible for protein packaging, suggesting this vulnerable site could be exploited to clear the viral infection," said the study’s first author, Laura Martin-Sancho.

"This is important information, but we still need to learn more about the biology of the virus and investigate if genetic variability within these ISGs correlates with COVID-19 severity."

The team plans to expand the study by investigating the infection dynamics of SARS-CoV-2 variants, focusing on how these may undercut vaccination efforts. "It's vitally important that we don't take our foot off the pedal of basic research efforts now that vaccines are helping control the pandemic," commented Chanda. 

 




Sources: EurekAlert, Molecular Cell.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 28, 2021
Immunology
Killers With a Hit on the Spike
JAN 28, 2021
Killers With a Hit on the Spike
Natural killer cells, or NK cells, are specialized immune cells of the innate immune system. Their job revolves around e ...
FEB 18, 2021
Immunology
Protective COVID Antibodies Found in Breast Milk
FEB 18, 2021
Protective COVID Antibodies Found in Breast Milk
University of Rochester researchers analyzing breast milk samples from mothers with COVID-19 found that it doesn’t ...
MAR 04, 2021
Immunology
Climate Change Tightens Its Grip on Hay Fever Sufferers
MAR 04, 2021
Climate Change Tightens Its Grip on Hay Fever Sufferers
There’s bad news for pollen allergy sufferers: New research has shown that climate change is making hay fever seas ...
MAR 16, 2021
Immunology
What Happens When Your Immune System Forgets
MAR 16, 2021
What Happens When Your Immune System Forgets
One of the most remarkable features of the immune system is its ability to “remember” past encounters with p ...
APR 06, 2021
Immunology
Lymphoma Patient Cured by "Reeducating" their Immune System
APR 06, 2021
Lymphoma Patient Cured by "Reeducating" their Immune System
Australian researchers have used a breakthrough therapy to cure a patient diagnosed with a rare brain lymphoma, a form o ...
MAY 20, 2021
Immunology
Why Delaying the 2nd COVID Shot is Paying Off for Some
MAY 20, 2021
Why Delaying the 2nd COVID Shot is Paying Off for Some
A new study indicates that delaying the second “booster” dose of the Pfizer-BioNTech COVID vaccine (to 11-12 ...
Loading Comments...